FDA Adverse Event
Injury
Summary report: N
GORE EXCLUDER AAA ENDOPROSTHESIS
MDR report key: 1910372
·
Received November 24, 2010
Report
- Report Number
- 2953161-2010-00215
- Event Type
- Injury
- Date Received
- November 24, 2010
- Date of Event
- December 1, 2009
- Report Date
- November 24, 2010
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
A REVIEW OF THE MANUFACTURING PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS.
Description of Event or Problem · 1
ON (B)(6), 2007, THE PT WAS IMPLANTED WITH TWO GORE EXCLUDER AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON (B)(6), 2009, A COMPUTED TOMOGRAPHY REVEALED A PROXIMAL TYPE I ENDOLEAK. ON (B)(6), 2009, A F/U COMPUTED TOMOGRAPHY REVEALED A PERSISTENT PROXIMAL TYPE I ENDOLEAK. ON (B)(6), 2010, THE PT WAS IMPLANTED WITH A GORE EXCLUDER AAA ENDOPROSTHESIS AORTIC EXTENDER COMPONENT TO TREAT THE PROXIMAL TYPE I ENDOLEAK. THE ENDOLEAK WAS RESOLVED AND NO FURTHER COMPLICATIONS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | WLG425 | 05262025 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 71 YR | Hospitalization| R | ALBUTEROL| PLAVIX| CALCIUM PLUS VITAMIN D| MAXZIDE| LISINOPRIL| MULTI-VITAMIN| CRESTOR| ASPIRIN| TOPROL| NIASPIN| CHLORPHENIRAMINE| SINGULAIR |